Indianapolis-area hospitals spent billions on construction in the past decade and increasingly tried to poach patients from one another’s territories. Yet last year—one of the worst economically in recent history—21 of 26 hospitals still were able to show operating profits.
Advantis Medical Inc., a maker of cases and trays for surgical instruments, plans to add more than 100 jobs in Greenwood over the next five years.
The bill has the potential to affect more than 250,000 Indiana workers in up to 24 categories of licensed professionals, including doctors, dentists, pharmacists, nurses, chiropractors, hypnotists, dietitians and even veterinarians.
The local startup expects to raise another $1.3 million this year and launch pilots of a new mobile device connecting patients with doctors.
An investigation found that lab employees kicked, threw, and dragged dogs; lifted rabbits by their ears and puppies by their throats; violently slammed cats into cages; and exposed animals to toxic chemicals.
Contractors starving for work are submitting more competitive bids, which so far has led to about $10 million in savings, hospital official says.
All nine Republicans—count 'em—have signed a pledge. What is that telling us?
Neurosciences center and administrative building would employ workers with annual salaries ranging from $27,000 for clerical staff to as high as $104,000 for management.
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
St. Vincent Health is moving aggressively to expand its transplant program in a direct challenge to Clarian Health’s dominance
in the field. The Indianapolis-based hospital system filed in July for permission to conduct pancreas transplants. And down
the road, it’s eyeing liver and maybe even lung transplants.
A dozen potential products designed to slow or stop clumps of protein from forming in the brain, a condition linked to the
disease since 1906, have failed in mid- to late-stage testing since 2003.
Studies showed that the treatment did not slow the disease's progression. It's just the latest setback for the pharmaceutical
giant, which lost a patent lawsuit over a major drug last week and faces an unprecedented number of patent expirations through
2014.
Nate Feltman, former state secretary of commerce, has left his partnership position at Baker & Daniels LLP to become president
of Home Health Depot LLP, a
growing home-medical-equipment supplier.
Satori Pointe is being marketed as a campus where medical offices, fitness-oriented retailers and residents would co-exist.
A U.S. appeals court Wednesday said a lower court was correct to invalidate a patent on the medicine that expires in 2013.
Gemzar generated $1.36 billion in global sales in 2009.
Marion County survey finds 80 percent of respondents in debt to local hospitals, with about half saying they were never informed
about the availability
of charity care or payment plans.
Massachusetts-based Alnara Pharmaceuticals Inc. is a privately held company
developing an enzyme-replacement therapy for disorders of the pancreas.
Clarian Health is launching its own health insurance plan, the boldest of several initiatives at Indianapolis hospitals to
bypass health insurers and provide health benefits directly to employers.
David Hartley pulled $85,000 from his savings six years ago to buy Home Health Depot Inc. Nearly six years later, Hartley
has reinvented the Indianapolis-based home medical equipment supplier, growing from a single office in Greenwood to 12 locations
in Indiana and Illinois—and increasing annual revenue from $300,000 to more than $6.7 million.
The program currently includes 1,200 physicians—about 10 percent of all doctors in Indiana.
